发明申请
US20070254898A1 Thienopyrimidine and Thienopyridine Derivatives Substituted with Cyclic Amino Group
失效
用环氨基取代的噻吩并嘧啶和噻吩并吡啶衍生物
- 专利标题: Thienopyrimidine and Thienopyridine Derivatives Substituted with Cyclic Amino Group
- 专利标题(中): 用环氨基取代的噻吩并嘧啶和噻吩并吡啶衍生物
-
申请号: US10584951申请日: 2005-01-06
-
公开(公告)号: US20070254898A1公开(公告)日: 2007-11-01
- 发明人: Atsuro Nakazato , Taketoshi Okubo , Dai Nozawa , Tomoko Tamita , Ludo Kennis
- 申请人: Atsuro Nakazato , Taketoshi Okubo , Dai Nozawa , Tomoko Tamita , Ludo Kennis
- 优先权: JP2004-001310 20040106
- 国际申请: PCT/JP05/00318 WO 20050106
- 主分类号: A61K31/519
- IPC分类号: A61K31/519 ; A61K31/435 ; C07D471/02 ; C07D487/00
摘要:
[Problem to be Solved] An object of the present invention is to provide an antagonist against CRF receptors which is effective as a therapeutic or prophylactic agent for diseases in which CRF is considered to be involved, such as depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastral diseases, drug dependence, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, cephalic external wound, inflammation, immunity-related diseases, alpecia, irritable bowel syndrome, sleep disorders, epilepsy, dermatitides, schizophrenia, etc. [Solution] A thienopyrimidine or thienopyridine derivative substituted with a cyclic amino group represented by the following formula [I]: has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved.
公开/授权文献
信息查询
IPC分类: